Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial

American Heart Journal

Volumn 166, Issue 3, 2013, Pages 474-480

  Brilakis, Emmanouil S ^a   Held, Claes ^b   Meier, Bernhard ^c   Cools, Frank ^d   Claeys, Marc J ^e   Cornel, Jan H ^f   Aylward, Philip ^g   Lewis, Basil S ^h   Weaver, Douglas ⁱ   Brandrup Wognsen, Gunnar ^j   Stevens, Susanna R ^k   Himmelmann, Anders ^j   Wallentin, Lars ^b   James, Stefan K ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF BERN   (Switzerland)

^d Algemeen Ziekenhuis Klina   (Belgium)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f Location Alkmaar   (Netherlands)

^g FLINDERS UNIVERSITY   (Australia)

^h CARMEL MEDICAL CENTER   (Israel)

ⁱ HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^j ASTRAZENECA R AND D   (Sweden)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICAGRELOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADENOSINE; AGED; CORONARY ARTERY BYPASS; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84883807129     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.06.019     Document Type: Article

References (24)

1. E.S. Brilakis, A.F. Hernandez, and D. Dai Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program Circulation 120 2009 560 567
2. E.S. Brilakis, J.A. de Lemos, and C.P. Cannon Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials) Am J Cardiol 102 2008 552 558
3. S.J. Shah, D.D. Waters, and P. Barter Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery J Am Coll Cardiol 51 2008 1938 1943
4. D.L. Bhatt, D.P. Chew, and A.T. Hirsch Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery Circulation 103 2001 363 368
5. L. Chen, P. Theroux, and J. Lesperance Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery J Am Coll Cardiol 28 1996 1493 1499
6. C. Lichtenwalter, J.A. de Lemos, and M. Roesle Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the stenting of saphenous vein grafts trial J Am Coll Cardiol Intv 2009 in press
7. E.S. Brilakis, C. Lichtenwalter, and J.A. de Lemos A randomized- controlled trial of a paclitaxel-eluting stent vs a similar bare metal stent in saphenous vein graft lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial J Am Coll Cardiol 53 2009 919 928
8. S.G. Ellis, S.J. Brener, and S. DeLuca Late myocardial ischemic events after saphenous vein graft intervention-importance of initially "nonsignificant" vein graft lesions Am J Cardiol 79 1997 1460 1464
9. R.H. Mehta, E. Honeycutt, and E.D. Peterson Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft Circulation 114 2006 I396 I401
10. A.R. Abdel-Karim, S. Banerjee, and E.S. Brilakis Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes J Invasive Cardiol 22 2010 253 257
11. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
12. S. James, A. Akerblom, and C.P. Cannon Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J 157 2009 599 605
13. D.D. Waters, A. Walling, and D. Roy Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris Am J Cardiol 58 1986 465 469
14. A. Wiseman, D.D. Waters, and A. Walling Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery J Am Coll Cardiol 12 1988 873 880
15. N.S. Kleiman, H.V. Anderson, and W.J. Rogers Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry) Am J Cardiol 77 1996 227 231
16. V. Mathew, P.B. Berger, and R.J. Lennon Comparison of percutaneous interventions for unstable angina pectoris in patients with and without previous coronary artery bypass grafting Am J Cardiol 86 2000 931 937
17. M. Labinaz, R. Kilaru, and K. Pieper Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial Circulation 105 2002 322 327
18. S.J. Servoss, Y. Wan, and S.M. Snapinn Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial Am J Cardiol 93 2004 843 847
19. D.M. Boatman, B. Saeed, and I. Varghese Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events Heart Vessels 24 2009 241 246
20. E.P. Gurfinkel, R. Perez de la Hoz, and V.M. Brito Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery Int J Cardiol 119 2007 65 72
21. G.M. Fitzgibbon, H.P. Kafka, and A.J. Leach Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626
22. D.L. Bhatt, K.A. Fox, and W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
23. K.A. Fox, S.R. Mehta, and R. Peters Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
24. E.S. Brilakis, S.V. Rao, and S. Banerjee Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients a report from the national cardiovascular data registry JACC Cardiovasc Interv 4 2011 844 850